scispace - formally typeset
J

James M. Trzaskos

Researcher at Bristol-Myers Squibb

Publications -  29
Citations -  2445

James M. Trzaskos is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Hydroxamic acid & Aggrecanase. The author has an hindex of 22, co-authored 29 publications receiving 2344 citations.

Papers
More filters
Journal ArticleDOI

Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus

TL;DR: The strong potential of cannabinoids for inducing long-term alterations in hippocampal neurons through the activation of the ERK pathway may be important for the physiological control of synaptic plasticity and for the general effects of THC in the context of drug abuse.
Journal ArticleDOI

Aggrecan protects cartilage collagen from proteolytic cleavage.

TL;DR: It is suggested that aggrecan plays a protective role in preventing degradation of collagen fibrils, and that an aggre canase inhibitor may impart overall cartilage protection.
Journal ArticleDOI

Role of the ERK pathway in psychostimulant-induced locomotor sensitization

TL;DR: Results show that ERK has a minor contribution to the acute locomotor effects of psychostimulants or to the expression of sensitized responses, whereas it is crucial for the acquisition of locomotor sensitization and psychostIMulant-conditioned locomotor response.
Journal ArticleDOI

Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice.

TL;DR: It is shown here that COX-2-derived prostaglandins (PGs) are important for uterine vascular permeability and angiogenesis during implantation and decidualization, suggesting that one cause of the failure of these latter processes in Cox-2(−/−) mice is the deregulated vascular events in the absence of COx-2.